Report banner
Home
Industries
Healthcare
Pharmaceutical
report thumbnailAntidepressants Market

Antidepressants Market 2024 to Grow at 21.2 CAGR with 11.67 USD Billion  Market Size: Analysis and Forecasts 2032

Antidepressants Market by Drug Class (Selective Serotonin Reuptake Inhibitors, Serotonin & Norepinephrine Reuptake Inhibitors, Atypical Antidepressants, Tricyclic Antidepressants), by Disorder (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy), by North America (By Drug Class, By Disorder, By Distribution Channel, By Country), by Europe (By Drug Class, By Disorder, By Distribution Channel, By Country), by Asia Pacific (By Drug Class, By Disorder, By Distribution Channel, By Country), by Latin America (By Drug Class, By Disorder, By Distribution Channel, By Country), by The Middle East & Africa (By Drug Class, By Disorder, By Distribution Channel, By Country) Forecast 2024-2032

Jul 11 2024
Base Year: 2023
180 Pages
Market Research Future Logo

Antidepressants Market 2024 to Grow at 21.2 CAGR with 11.67 USD Billion  Market Size: Analysis and Forecasts 2032

Key Insights

The Antidepressants Market size was valued at USD 11.67 USD Billion in 2023 and is projected to reach USD 44.83 USD Billion by 2032, exhibiting a CAGR of 21.2 % during the forecast period. Having said that, antidepressants refer to drugs which are intended to help reduce symptoms of depression and other related mental disorders. These drugs aim to level the chemicals that influence moods and feelings in the brain. There are several types of antidepressants: Specific examples are selective serotonin reuptake inhibitors (SSRIs) including fluoxetine and sertraline, serotonin-norepinephrine reuptake inhibitors (SNRIs) including venlafaxine, tricyclic antidepressants (TCAs) including amitriptyline and monoamine oxidase inhibitors (MAOIs) including phenelzine. It is important to understand that each of them has its characteristics and additionally possesses an action on certain neurotransmitters that help stabilize the mood and reduce anxiety. Selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, tricyclic antidepressants, monoamine oxidase inhibitors and others are used in the treatment of major depressive disorder, anxiety disorders, chronic pain and some hormonal disorders. The advantages of having antidepressants include the enhancement of mood, sleep quality, appetite, and functioning.

Antidepressants Market Research Report - Market Size, Growth & Forecast

Antidepressants Trends

  • Growing emphasis on mental health and wellbeing
  • Increasing awareness of available treatment options
  • Development of novel and more effective antidepressant medications
  • Shift towards personalized medicine and targeted therapies

Driving Forces: What's Propelling the Antidepressants Market

  • Rising prevalence of mental health disorders such as depression and anxiety
  • Increasing access to healthcare and mental health services
  • Government initiatives to promote mental health awareness and treatment
  • Technological advancements leading to the development of innovative antidepressants
  • Growing demand for non-pharmacological approaches, such as psychotherapy

Challenges and Restraints in Antidepressants Market

  • Side effects associated with antidepressants
  • Limited efficacy of some antidepressants
  • Stigma surrounding mental health disorders
  • High cost of antidepressants
  • Potential for abuse and misuse

Emerging Trends in Antidepressants

  • Development of long-acting formulations to improve adherence
  • Use of artificial intelligence (AI) in medication selection and monitoring
  • Precision medicine approaches to tailor treatment based on individual patient characteristics
  • Integration of telehealth and mobile apps to enhance access to care

Growth Catalysts in the Antidepressant Industry

Antidepressants Market Growth
  • Increasing investment in research and development
  • Strategic partnerships and collaborations between pharmaceutical companies
  • Government funding for mental health research
  • Growing consumer demand for effective and accessible treatments
  • Favorable reimbursement policies

Market Segmentation: Antidepressants Analysis

Drug Class:

  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin & Norepinephrine Reuptake Inhibitors (SNRIs)
  • Atypical Antidepressants
  • Tricyclic Antidepressants

Disorder:

  • Major Depressive Disorder
  • Obsessive-Compulsive Disorder
  • Generalized Anxiety Disorder

Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy

Leading Players in the Antidepressants Market

  • H. Lundbeck A/S (Denmark, Europe) 
  • GlaxoSmithKline plc (Brentford, U.K) 
  • Eli Lilly and Company (Indiana, U.S) 
  • Janssen Pharmaceuticals (Beerse, Belgium) 
  • Pfizer Inc. (New York, U.S) 
  • Merck & Co. Inc. (New Jersey, U.S) 
  • AstraZeneca (Cambridge, U.K) 
  • Bristol-Myers Squibb (New York, U.S) 
  • Teva Pharmaceutical Industries Ltd. (Petah Tikva, Israel) 
  • AbbVie Inc (U.S)

Significant Developments in the Antidepressant Sector

  • Launch of novel antidepressants with improved efficacy and reduced side effects
  • FDA approval of ketamine for treatment-resistant depression
  • Development of transcranial magnetic stimulation (TMS) as an alternative treatment option
  • Growing adoption of personalized medicine approaches

Comprehensive Coverage Antidepressants Market Report

DROCT

  • Drivers: Rising prevalence of mental health disorders, increasing awareness
  • Restraints: Side effects, cost
  • Opportunities: Development of innovative treatments, personalized medicine
  • Challenges: Stigma, access to care

Pricing Analysis

  • Branded versus generic drugs
  • Price variations across regions

Import And Export Analysis

  • Key exporting and importing countries
  • Trade barriers and regulations

Segmentation

  • By drug class, disorder, distribution channel

Patent/Trademark Analysis

  • Patented antidepressants
  • Generic drug approvals

Antidepressants Market REPORT HIGHLIGHTS

AspectsDetails
Study Period 2018-2032
Base Year 2023
Estimated Year 2024
Forecast Period2024-2032
Historical Period2018-2023
Growth RateCAGR of 21.2% from 2018-2032
Segmentation
    • By Drug Class
      • Selective Serotonin Reuptake Inhibitors
      • Serotonin & Norepinephrine Reuptake Inhibitors
      • Atypical Antidepressants
      • Tricyclic Antidepressants
    • By Disorder
      • Major Depressive Disorder
      • Obsessive-Compulsive Disorder
      • Generalized Anxiety Disorder
    • By Distribution Channel
      • Hospital Pharmacy
      • Retail Pharmacy
  • By Geography
    • North America
      • By Drug Class
      • By Disorder
      • By Distribution Channel
      • By Country
    • Europe
      • By Drug Class
      • By Disorder
      • By Distribution Channel
      • By Country
    • Asia Pacific
      • By Drug Class
      • By Disorder
      • By Distribution Channel
      • By Country
    • Latin America
      • By Drug Class
      • By Disorder
      • By Distribution Channel
      • By Country
    • The Middle East & Africa
      • By Drug Class
      • By Disorder
      • By Distribution Channel
      • By Country

Frequently Asked Questions

Table Of Content
  1. 1. Introduction
    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions
  2. 2. Executive Summary
    • 2.1. Introduction
  3. 3. Market Dynamics
    • 3.1. Introduction
      • 3.2. Market Drivers
        • 3.2.1. Increasing Public Awareness for Safer Medicines to Stimulate Market Value
      • 3.3. Market Restrains
        • 3.3.1. Gaps in Required Treatments & Adverse Effects of Current Therapeutics to Limit Market Growth
      • 3.4. Market Trends
        • 3.4.1. Manufacturers focusing on the Development of Mitral Valve Product will drive the Market
  4. 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  5. 5. Global Antidepressants Market Analysis, Insights and Forecast, 2018-2030
    • 5.1. Market Analysis, Insights and Forecast - by Drug Class
      • 5.1.1. Selective Serotonin Reuptake Inhibitors
      • 5.1.2. Serotonin & Norepinephrine Reuptake Inhibitors
      • 5.1.3. Atypical Antidepressants
      • 5.1.4. Tricyclic Antidepressants
    • 5.2. Market Analysis, Insights and Forecast - by Disorder
      • 5.2.1. Major Depressive Disorder
      • 5.2.2. Obsessive-Compulsive Disorder
      • 5.2.3. Generalized Anxiety Disorder
    • 5.3. Market Analysis, Insights and Forecast - by Distribution Channel
      • 5.3.1. Hospital Pharmacy
      • 5.3.2. Retail Pharmacy
    • 5.4. Market Analysis, Insights and Forecast - by Region
      • 5.4.1. North America
      • 5.4.2. Europe
      • 5.4.3. Asia Pacific
      • 5.4.4. Latin America
      • 5.4.5. The Middle East & Africa
  6. 6. North America Antidepressants Market Analysis, Insights and Forecast, 2018-2030
    • 6.1. Market Analysis, Insights and Forecast - by Drug Class
      • 6.1.1. Selective Serotonin Reuptake Inhibitors
      • 6.1.2. Serotonin & Norepinephrine Reuptake Inhibitors
      • 6.1.3. Atypical Antidepressants
      • 6.1.4. Tricyclic Antidepressants
    • 6.2. Market Analysis, Insights and Forecast - by Disorder
      • 6.2.1. Major Depressive Disorder
      • 6.2.2. Obsessive-Compulsive Disorder
      • 6.2.3. Generalized Anxiety Disorder
    • 6.3. Market Analysis, Insights and Forecast - by Distribution Channel
      • 6.3.1. Hospital Pharmacy
      • 6.3.2. Retail Pharmacy
  7. 7. Europe Antidepressants Market Analysis, Insights and Forecast, 2018-2030
    • 7.1. Market Analysis, Insights and Forecast - by Drug Class
      • 7.1.1. Selective Serotonin Reuptake Inhibitors
      • 7.1.2. Serotonin & Norepinephrine Reuptake Inhibitors
      • 7.1.3. Atypical Antidepressants
      • 7.1.4. Tricyclic Antidepressants
    • 7.2. Market Analysis, Insights and Forecast - by Disorder
      • 7.2.1. Major Depressive Disorder
      • 7.2.2. Obsessive-Compulsive Disorder
      • 7.2.3. Generalized Anxiety Disorder
    • 7.3. Market Analysis, Insights and Forecast - by Distribution Channel
      • 7.3.1. Hospital Pharmacy
      • 7.3.2. Retail Pharmacy
  8. 8. Asia Pacific Antidepressants Market Analysis, Insights and Forecast, 2018-2030
    • 8.1. Market Analysis, Insights and Forecast - by Drug Class
      • 8.1.1. Selective Serotonin Reuptake Inhibitors
      • 8.1.2. Serotonin & Norepinephrine Reuptake Inhibitors
      • 8.1.3. Atypical Antidepressants
      • 8.1.4. Tricyclic Antidepressants
    • 8.2. Market Analysis, Insights and Forecast - by Disorder
      • 8.2.1. Major Depressive Disorder
      • 8.2.2. Obsessive-Compulsive Disorder
      • 8.2.3. Generalized Anxiety Disorder
    • 8.3. Market Analysis, Insights and Forecast - by Distribution Channel
      • 8.3.1. Hospital Pharmacy
      • 8.3.2. Retail Pharmacy
  9. 9. Latin America Antidepressants Market Analysis, Insights and Forecast, 2018-2030
    • 9.1. Market Analysis, Insights and Forecast - by Drug Class
      • 9.1.1. Selective Serotonin Reuptake Inhibitors
      • 9.1.2. Serotonin & Norepinephrine Reuptake Inhibitors
      • 9.1.3. Atypical Antidepressants
      • 9.1.4. Tricyclic Antidepressants
    • 9.2. Market Analysis, Insights and Forecast - by Disorder
      • 9.2.1. Major Depressive Disorder
      • 9.2.2. Obsessive-Compulsive Disorder
      • 9.2.3. Generalized Anxiety Disorder
    • 9.3. Market Analysis, Insights and Forecast - by Distribution Channel
      • 9.3.1. Hospital Pharmacy
      • 9.3.2. Retail Pharmacy
  10. 10. The Middle East & Africa Antidepressants Market Analysis, Insights and Forecast, 2018-2030
    • 10.1. Market Analysis, Insights and Forecast - by Drug Class
      • 10.1.1. Selective Serotonin Reuptake Inhibitors
      • 10.1.2. Serotonin & Norepinephrine Reuptake Inhibitors
      • 10.1.3. Atypical Antidepressants
      • 10.1.4. Tricyclic Antidepressants
    • 10.2. Market Analysis, Insights and Forecast - by Disorder
      • 10.2.1. Major Depressive Disorder
      • 10.2.2. Obsessive-Compulsive Disorder
      • 10.2.3. Generalized Anxiety Disorder
    • 10.3. Market Analysis, Insights and Forecast - by Distribution Channel
      • 10.3.1. Hospital Pharmacy
      • 10.3.2. Retail Pharmacy
  11. 11. North America Antidepressants Market Analysis, Insights and Forecast, 2018-2030
      • 11.1. Market Analysis, Insights and Forecast - By Drug Class
        • 11.1.1 Selective Serotonin Reuptake Inhibitors
        • 11.1.2 Serotonin & Norepinephrine Reuptake Inhibitors
        • 11.1.3 Atypical Antidepressants
        • 11.1.4 Tricyclic Antidepressants
      • 11.2. Market Analysis, Insights and Forecast - By Disorder
        • 11.2.1 Major Depressive Disorder
        • 11.2.2 Obsessive-Compulsive Disorder
        • 11.2.3 Generalized Anxiety Disorder
      • 11.3. Market Analysis, Insights and Forecast - By Distribution Channel
        • 11.3.1 Hospital Pharmacy
        • 11.3.2 Retail Pharmacy
      • 11.4. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 11.4.1 United States
        • 11.4.2 Canada
        • 11.4.3 Mexico
  12. 12. South America Antidepressants Market Analysis, Insights and Forecast, 2018-2030
      • 12.1. Market Analysis, Insights and Forecast - By Drug Class
        • 12.1.1 Selective Serotonin Reuptake Inhibitors
        • 12.1.2 Serotonin & Norepinephrine Reuptake Inhibitors
        • 12.1.3 Atypical Antidepressants
        • 12.1.4 Tricyclic Antidepressants
      • 12.2. Market Analysis, Insights and Forecast - By Disorder
        • 12.2.1 Major Depressive Disorder
        • 12.2.2 Obsessive-Compulsive Disorder
        • 12.2.3 Generalized Anxiety Disorder
      • 12.3. Market Analysis, Insights and Forecast - By Distribution Channel
        • 12.3.1 Hospital Pharmacy
        • 12.3.2 Retail Pharmacy
      • 12.4. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 12.4.1 Brazil
        • 12.4.2 Argentina
        • 12.4.3 Rest of South America
  13. 13. Europe Antidepressants Market Analysis, Insights and Forecast, 2018-2030
      • 13.1. Market Analysis, Insights and Forecast - By Drug Class
        • 13.1.1 Selective Serotonin Reuptake Inhibitors
        • 13.1.2 Serotonin & Norepinephrine Reuptake Inhibitors
        • 13.1.3 Atypical Antidepressants
        • 13.1.4 Tricyclic Antidepressants
      • 13.2. Market Analysis, Insights and Forecast - By Disorder
        • 13.2.1 Major Depressive Disorder
        • 13.2.2 Obsessive-Compulsive Disorder
        • 13.2.3 Generalized Anxiety Disorder
      • 13.3. Market Analysis, Insights and Forecast - By Distribution Channel
        • 13.3.1 Hospital Pharmacy
        • 13.3.2 Retail Pharmacy
      • 13.4. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 13.4.1 Germany
        • 13.4.2 France
        • 13.4.3 Italy
        • 13.4.4 United Kingdom
        • 13.4.5 Netherlands
        • 13.4.6 Rest of Europe
  14. 14. Asia Pacific Antidepressants Market Analysis, Insights and Forecast, 2018-2030
      • 14.1. Market Analysis, Insights and Forecast - By Drug Class
        • 14.1.1 Selective Serotonin Reuptake Inhibitors
        • 14.1.2 Serotonin & Norepinephrine Reuptake Inhibitors
        • 14.1.3 Atypical Antidepressants
        • 14.1.4 Tricyclic Antidepressants
      • 14.2. Market Analysis, Insights and Forecast - By Disorder
        • 14.2.1 Major Depressive Disorder
        • 14.2.2 Obsessive-Compulsive Disorder
        • 14.2.3 Generalized Anxiety Disorder
      • 14.3. Market Analysis, Insights and Forecast - By Distribution Channel
        • 14.3.1 Hospital Pharmacy
        • 14.3.2 Retail Pharmacy
      • 14.4. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 14.4.1 China
        • 14.4.2 Japan
        • 14.4.3 India
        • 14.4.4 South Korea
        • 14.4.5 Taiwan
        • 14.4.6 Australia
        • 14.4.7 Rest of Asia-Pacific
  15. 15. MEA Antidepressants Market Analysis, Insights and Forecast, 2018-2030
      • 15.1. Market Analysis, Insights and Forecast - By Drug Class
        • 15.1.1 Selective Serotonin Reuptake Inhibitors
        • 15.1.2 Serotonin & Norepinephrine Reuptake Inhibitors
        • 15.1.3 Atypical Antidepressants
        • 15.1.4 Tricyclic Antidepressants
      • 15.2. Market Analysis, Insights and Forecast - By Disorder
        • 15.2.1 Major Depressive Disorder
        • 15.2.2 Obsessive-Compulsive Disorder
        • 15.2.3 Generalized Anxiety Disorder
      • 15.3. Market Analysis, Insights and Forecast - By Distribution Channel
        • 15.3.1 Hospital Pharmacy
        • 15.3.2 Retail Pharmacy
      • 15.4. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 15.4.1 Middle East
        • 15.4.2 Africa
  16. 16. Competitive Analysis
    • 16.1. Global Market Share Analysis 2023
      • 16.2. Company Profiles
        • 16.2.1 H. Lundbeck A/S (Denmark Europe)
          • 16.2.1.1. Overview
          • 16.2.1.2. Products
          • 16.2.1.3. SWOT Analysis
          • 16.2.1.4. Recent Developments
          • 16.2.1.5. Financials (Based on Availability)
        • 16.2.2 GlaxoSmithKline plc (Brentford U.K)
          • 16.2.2.1. Overview
          • 16.2.2.2. Products
          • 16.2.2.3. SWOT Analysis
          • 16.2.2.4. Recent Developments
          • 16.2.2.5. Financials (Based on Availability)
        • 16.2.3 Eli Lilly and Company (Indiana U.S)
          • 16.2.3.1. Overview
          • 16.2.3.2. Products
          • 16.2.3.3. SWOT Analysis
          • 16.2.3.4. Recent Developments
          • 16.2.3.5. Financials (Based on Availability)
        • 16.2.4 Janssen Pharmaceuticals (Beerse Belgium)
          • 16.2.4.1. Overview
          • 16.2.4.2. Products
          • 16.2.4.3. SWOT Analysis
          • 16.2.4.4. Recent Developments
          • 16.2.4.5. Financials (Based on Availability)
        • 16.2.5 Pfizer Inc. (New York U.S)
          • 16.2.5.1. Overview
          • 16.2.5.2. Products
          • 16.2.5.3. SWOT Analysis
          • 16.2.5.4. Recent Developments
          • 16.2.5.5. Financials (Based on Availability)
        • 16.2.6 Merck & Co. Inc. (New Jersey U.S)
          • 16.2.6.1. Overview
          • 16.2.6.2. Products
          • 16.2.6.3. SWOT Analysis
          • 16.2.6.4. Recent Developments
          • 16.2.6.5. Financials (Based on Availability)
        • 16.2.7 AstraZeneca (Cambridge U.K)
          • 16.2.7.1. Overview
          • 16.2.7.2. Products
          • 16.2.7.3. SWOT Analysis
          • 16.2.7.4. Recent Developments
          • 16.2.7.5. Financials (Based on Availability)
        • 16.2.8 Bristol-Myers Squibb (New York U.S)
          • 16.2.8.1. Overview
          • 16.2.8.2. Products
          • 16.2.8.3. SWOT Analysis
          • 16.2.8.4. Recent Developments
          • 16.2.8.5. Financials (Based on Availability)
        • 16.2.9 Teva Pharmaceutical Industries Ltd. (Petah Tikva Israel)
          • 16.2.9.1. Overview
          • 16.2.9.2. Products
          • 16.2.9.3. SWOT Analysis
          • 16.2.9.4. Recent Developments
          • 16.2.9.5. Financials (Based on Availability)
        • 16.2.10 AbbVie Inc (U.S)
          • 16.2.10.1. Overview
          • 16.2.10.2. Products
          • 16.2.10.3. SWOT Analysis
          • 16.2.10.4. Recent Developments
          • 16.2.10.5. Financials (Based on Availability)
List of Figures
  1. Figure 1: Global Antidepressants Market Revenue Breakdown (USD Billion, %) by Region 2023 & 2031
  2. Figure 2: Global Antidepressants Market Volume Breakdown (million units, %) by Region 2023 & 2031
  3. Figure 3: Global Antidepressants Market Revenue (USD Billion), by Drug Class 2023 & 2031
  4. Figure 4: Global Antidepressants Market Volume (million units), by Drug Class 2023 & 2031
  5. Figure 5: Global Antidepressants Market Revenue Share (%), by Drug Class 2023 & 2031
  6. Figure 6: Global Antidepressants Market Volume Share (%), by Drug Class 2023 & 2031
  7. Figure 7: Global Antidepressants Market Forecast (USD Billion), by Selective Serotonin Reuptake Inhibitors 2020 & 2031
  8. Figure 8: Global Antidepressants Market Forecast (million units), by Selective Serotonin Reuptake Inhibitors 2020 & 2031
  9. Figure 9: Global Antidepressants Market Forecast (USD Billion), by Serotonin & Norepinephrine Reuptake Inhibitors 2020 & 2031
  10. Figure 10: Global Antidepressants Market Forecast (million units), by Serotonin & Norepinephrine Reuptake Inhibitors 2020 & 2031
  11. Figure 11: Global Antidepressants Market Forecast (USD Billion), by Atypical Antidepressants 2020 & 2031
  12. Figure 12: Global Antidepressants Market Forecast (million units), by Atypical Antidepressants 2020 & 2031
  13. Figure 13: Global Antidepressants Market Forecast (USD Billion), by Tricyclic Antidepressants 2020 & 2031
  14. Figure 14: Global Antidepressants Market Forecast (million units), by Tricyclic Antidepressants 2020 & 2031
  15. Figure 15: Global Antidepressants Market Revenue (USD Billion), by Disorder 2023 & 2031
  16. Figure 16: Global Antidepressants Market Volume (million units), by Disorder 2023 & 2031
  17. Figure 17: Global Antidepressants Market Revenue Share (%), by Disorder 2023 & 2031
  18. Figure 18: Global Antidepressants Market Volume Share (%), by Disorder 2023 & 2031
  19. Figure 19: Global Antidepressants Market Forecast (USD Billion), by Major Depressive Disorder 2020 & 2031
  20. Figure 20: Global Antidepressants Market Forecast (million units), by Major Depressive Disorder 2020 & 2031
  21. Figure 21: Global Antidepressants Market Forecast (USD Billion), by Obsessive-Compulsive Disorder 2020 & 2031
  22. Figure 22: Global Antidepressants Market Forecast (million units), by Obsessive-Compulsive Disorder 2020 & 2031
  23. Figure 23: Global Antidepressants Market Forecast (USD Billion), by Generalized Anxiety Disorder 2020 & 2031
  24. Figure 24: Global Antidepressants Market Forecast (million units), by Generalized Anxiety Disorder 2020 & 2031
  25. Figure 25: Global Antidepressants Market Revenue (USD Billion), by Distribution Channel 2023 & 2031
  26. Figure 26: Global Antidepressants Market Volume (million units), by Distribution Channel 2023 & 2031
  27. Figure 27: Global Antidepressants Market Revenue Share (%), by Distribution Channel 2023 & 2031
  28. Figure 28: Global Antidepressants Market Volume Share (%), by Distribution Channel 2023 & 2031
  29. Figure 29: Global Antidepressants Market Forecast (USD Billion), by Hospital Pharmacy 2020 & 2031
  30. Figure 30: Global Antidepressants Market Forecast (million units), by Hospital Pharmacy 2020 & 2031
  31. Figure 31: Global Antidepressants Market Forecast (USD Billion), by Retail Pharmacy 2020 & 2031
  32. Figure 32: Global Antidepressants Market Forecast (million units), by Retail Pharmacy 2020 & 2031
  33. Figure 33: Global Antidepressants Market Revenue (USD Billion), by Region 2023 & 2031
  34. Figure 34: Global Antidepressants Market Volume (million units), by Region 2023 & 2031
  35. Figure 35: Global Antidepressants Market Revenue Share (%), by Region 2023 & 2031
  36. Figure 36: Global Antidepressants Market Volume Share (%), by Region 2023 & 2031
  37. Figure 37: North America Antidepressants Market Revenue (USD Billion), by Drug Class 2023 & 2031
  38. Figure 38: North America Antidepressants Market Volume (million units), by Drug Class 2023 & 2031
  39. Figure 39: North America Antidepressants Market Revenue Share (%), by Drug Class 2023 & 2031
  40. Figure 40: North America Antidepressants Market Volume Share (%), by Drug Class 2023 & 2031
  41. Figure 41: North America Antidepressants Market Revenue (USD Billion), by Disorder 2023 & 2031
  42. Figure 42: North America Antidepressants Market Volume (million units), by Disorder 2023 & 2031
  43. Figure 43: North America Antidepressants Market Revenue Share (%), by Disorder 2023 & 2031
  44. Figure 44: North America Antidepressants Market Volume Share (%), by Disorder 2023 & 2031
  45. Figure 45: North America Antidepressants Market Revenue (USD Billion), by Distribution Channel 2023 & 2031
  46. Figure 46: North America Antidepressants Market Volume (million units), by Distribution Channel 2023 & 2031
  47. Figure 47: North America Antidepressants Market Revenue Share (%), by Distribution Channel 2023 & 2031
  48. Figure 48: North America Antidepressants Market Volume Share (%), by Distribution Channel 2023 & 2031
  49. Figure 49: North America Antidepressants Market Revenue (USD Billion), by Country 2023 & 2031
  50. Figure 50: North America Antidepressants Market Volume (million units), by Country 2023 & 2031
  51. Figure 51: North America Antidepressants Market Revenue Share (%), by Country 2023 & 2031
  52. Figure 52: North America Antidepressants Market Volume Share (%), by Country 2023 & 2031
  53. Figure 53: South America Antidepressants Market Revenue (USD Billion), by Drug Class 2023 & 2031
  54. Figure 54: South America Antidepressants Market Volume (million units), by Drug Class 2023 & 2031
  55. Figure 55: South America Antidepressants Market Revenue Share (%), by Drug Class 2023 & 2031
  56. Figure 56: South America Antidepressants Market Volume Share (%), by Drug Class 2023 & 2031
  57. Figure 57: South America Antidepressants Market Revenue (USD Billion), by Disorder 2023 & 2031
  58. Figure 58: South America Antidepressants Market Volume (million units), by Disorder 2023 & 2031
  59. Figure 59: South America Antidepressants Market Revenue Share (%), by Disorder 2023 & 2031
  60. Figure 60: South America Antidepressants Market Volume Share (%), by Disorder 2023 & 2031
  61. Figure 61: South America Antidepressants Market Revenue (USD Billion), by Distribution Channel 2023 & 2031
  62. Figure 62: South America Antidepressants Market Volume (million units), by Distribution Channel 2023 & 2031
  63. Figure 63: South America Antidepressants Market Revenue Share (%), by Distribution Channel 2023 & 2031
  64. Figure 64: South America Antidepressants Market Volume Share (%), by Distribution Channel 2023 & 2031
  65. Figure 65: South America Antidepressants Market Revenue (USD Billion), by Country 2023 & 2031
  66. Figure 66: South America Antidepressants Market Volume (million units), by Country 2023 & 2031
  67. Figure 67: South America Antidepressants Market Revenue Share (%), by Country 2023 & 2031
  68. Figure 68: South America Antidepressants Market Volume Share (%), by Country 2023 & 2031
  69. Figure 69: Europe Antidepressants Market Revenue (USD Billion), by Drug Class 2023 & 2031
  70. Figure 70: Europe Antidepressants Market Volume (million units), by Drug Class 2023 & 2031
  71. Figure 71: Europe Antidepressants Market Revenue Share (%), by Drug Class 2023 & 2031
  72. Figure 72: Europe Antidepressants Market Volume Share (%), by Drug Class 2023 & 2031
  73. Figure 73: Europe Antidepressants Market Revenue (USD Billion), by Disorder 2023 & 2031
  74. Figure 74: Europe Antidepressants Market Volume (million units), by Disorder 2023 & 2031
  75. Figure 75: Europe Antidepressants Market Revenue Share (%), by Disorder 2023 & 2031
  76. Figure 76: Europe Antidepressants Market Volume Share (%), by Disorder 2023 & 2031
  77. Figure 77: Europe Antidepressants Market Revenue (USD Billion), by Distribution Channel 2023 & 2031
  78. Figure 78: Europe Antidepressants Market Volume (million units), by Distribution Channel 2023 & 2031
  79. Figure 79: Europe Antidepressants Market Revenue Share (%), by Distribution Channel 2023 & 2031
  80. Figure 80: Europe Antidepressants Market Volume Share (%), by Distribution Channel 2023 & 2031
  81. Figure 81: Europe Antidepressants Market Revenue (USD Billion), by Country 2023 & 2031
  82. Figure 82: Europe Antidepressants Market Volume (million units), by Country 2023 & 2031
  83. Figure 83: Europe Antidepressants Market Revenue Share (%), by Country 2023 & 2031
  84. Figure 84: Europe Antidepressants Market Volume Share (%), by Country 2023 & 2031
  85. Figure 85: Asia Pacific Antidepressants Market Revenue (USD Billion), by Drug Class 2023 & 2031
  86. Figure 86: Asia Pacific Antidepressants Market Volume (million units), by Drug Class 2023 & 2031
  87. Figure 87: Asia Pacific Antidepressants Market Revenue Share (%), by Drug Class 2023 & 2031
  88. Figure 88: Asia Pacific Antidepressants Market Volume Share (%), by Drug Class 2023 & 2031
  89. Figure 89: Asia Pacific Antidepressants Market Revenue (USD Billion), by Disorder 2023 & 2031
  90. Figure 90: Asia Pacific Antidepressants Market Volume (million units), by Disorder 2023 & 2031
  91. Figure 91: Asia Pacific Antidepressants Market Revenue Share (%), by Disorder 2023 & 2031
  92. Figure 92: Asia Pacific Antidepressants Market Volume Share (%), by Disorder 2023 & 2031
  93. Figure 93: Asia Pacific Antidepressants Market Revenue (USD Billion), by Distribution Channel 2023 & 2031
  94. Figure 94: Asia Pacific Antidepressants Market Volume (million units), by Distribution Channel 2023 & 2031
  95. Figure 95: Asia Pacific Antidepressants Market Revenue Share (%), by Distribution Channel 2023 & 2031
  96. Figure 96: Asia Pacific Antidepressants Market Volume Share (%), by Distribution Channel 2023 & 2031
  97. Figure 97: Asia Pacific Antidepressants Market Revenue (USD Billion), by Country 2023 & 2031
  98. Figure 98: Asia Pacific Antidepressants Market Volume (million units), by Country 2023 & 2031
  99. Figure 99: Asia Pacific Antidepressants Market Revenue Share (%), by Country 2023 & 2031
  100. Figure 100: Asia Pacific Antidepressants Market Volume Share (%), by Country 2023 & 2031
  101. Figure 101: MEA Antidepressants Market Revenue (USD Billion), by Drug Class 2023 & 2031
  102. Figure 102: MEA Antidepressants Market Volume (million units), by Drug Class 2023 & 2031
  103. Figure 103: MEA Antidepressants Market Revenue Share (%), by Drug Class 2023 & 2031
  104. Figure 104: MEA Antidepressants Market Volume Share (%), by Drug Class 2023 & 2031
  105. Figure 105: MEA Antidepressants Market Revenue (USD Billion), by Disorder 2023 & 2031
  106. Figure 106: MEA Antidepressants Market Volume (million units), by Disorder 2023 & 2031
  107. Figure 107: MEA Antidepressants Market Revenue Share (%), by Disorder 2023 & 2031
  108. Figure 108: MEA Antidepressants Market Volume Share (%), by Disorder 2023 & 2031
  109. Figure 109: MEA Antidepressants Market Revenue (USD Billion), by Distribution Channel 2023 & 2031
  110. Figure 110: MEA Antidepressants Market Volume (million units), by Distribution Channel 2023 & 2031
  111. Figure 111: MEA Antidepressants Market Revenue Share (%), by Distribution Channel 2023 & 2031
  112. Figure 112: MEA Antidepressants Market Volume Share (%), by Distribution Channel 2023 & 2031
  113. Figure 113: MEA Antidepressants Market Revenue (USD Billion), by Country 2023 & 2031
  114. Figure 114: MEA Antidepressants Market Volume (million units), by Country 2023 & 2031
  115. Figure 115: MEA Antidepressants Market Revenue Share (%), by Country 2023 & 2031
  116. Figure 116: MEA Antidepressants Market Volume Share (%), by Country 2023 & 2031
  117. Figure 117: North America Antidepressants Market Revenue (USD Billion), by Drug Class 2023 & 2031
  118. Figure 118: North America Antidepressants Market Volume (million units), by Drug Class 2023 & 2031
  119. Figure 119: North America Antidepressants Market Revenue Share (%), by Drug Class 2023 & 2031
  120. Figure 120: North America Antidepressants Market Volume Share (%), by Drug Class 2023 & 2031
  121. Figure 121: North America Antidepressants Market Revenue (USD Billion), by Disorder 2023 & 2031
  122. Figure 122: North America Antidepressants Market Volume (million units), by Disorder 2023 & 2031
  123. Figure 123: North America Antidepressants Market Revenue Share (%), by Disorder 2023 & 2031
  124. Figure 124: North America Antidepressants Market Volume Share (%), by Disorder 2023 & 2031
  125. Figure 125: North America Antidepressants Market Revenue (USD Billion), by Distribution Channel 2023 & 2031
  126. Figure 126: North America Antidepressants Market Volume (million units), by Distribution Channel 2023 & 2031
  127. Figure 127: North America Antidepressants Market Revenue Share (%), by Distribution Channel 2023 & 2031
  128. Figure 128: North America Antidepressants Market Volume Share (%), by Distribution Channel 2023 & 2031
  129. Figure 129: North America Antidepressants Market Revenue (USD Billion), by Country 2023 & 2031
  130. Figure 130: North America Antidepressants Market Volume (million units), by Country 2023 & 2031
  131. Figure 131: North America Antidepressants Market Revenue Share (%), by Country 2023 & 2031
  132. Figure 132: North America Antidepressants Market Volume Share (%), by Country 2023 & 2031
  133. Figure 133: Europe Antidepressants Market Revenue (USD Billion), by Drug Class 2023 & 2031
  134. Figure 134: Europe Antidepressants Market Volume (million units), by Drug Class 2023 & 2031
  135. Figure 135: Europe Antidepressants Market Revenue Share (%), by Drug Class 2023 & 2031
  136. Figure 136: Europe Antidepressants Market Volume Share (%), by Drug Class 2023 & 2031
  137. Figure 137: Europe Antidepressants Market Revenue (USD Billion), by Disorder 2023 & 2031
  138. Figure 138: Europe Antidepressants Market Volume (million units), by Disorder 2023 & 2031
  139. Figure 139: Europe Antidepressants Market Revenue Share (%), by Disorder 2023 & 2031
  140. Figure 140: Europe Antidepressants Market Volume Share (%), by Disorder 2023 & 2031
  141. Figure 141: Europe Antidepressants Market Revenue (USD Billion), by Distribution Channel 2023 & 2031
  142. Figure 142: Europe Antidepressants Market Volume (million units), by Distribution Channel 2023 & 2031
  143. Figure 143: Europe Antidepressants Market Revenue Share (%), by Distribution Channel 2023 & 2031
  144. Figure 144: Europe Antidepressants Market Volume Share (%), by Distribution Channel 2023 & 2031
  145. Figure 145: Europe Antidepressants Market Revenue (USD Billion), by Country 2023 & 2031
  146. Figure 146: Europe Antidepressants Market Volume (million units), by Country 2023 & 2031
  147. Figure 147: Europe Antidepressants Market Revenue Share (%), by Country 2023 & 2031
  148. Figure 148: Europe Antidepressants Market Volume Share (%), by Country 2023 & 2031
  149. Figure 149: Asia Pacific Antidepressants Market Revenue (USD Billion), by Drug Class 2023 & 2031
  150. Figure 150: Asia Pacific Antidepressants Market Volume (million units), by Drug Class 2023 & 2031
  151. Figure 151: Asia Pacific Antidepressants Market Revenue Share (%), by Drug Class 2023 & 2031
  152. Figure 152: Asia Pacific Antidepressants Market Volume Share (%), by Drug Class 2023 & 2031
  153. Figure 153: Asia Pacific Antidepressants Market Revenue (USD Billion), by Disorder 2023 & 2031
  154. Figure 154: Asia Pacific Antidepressants Market Volume (million units), by Disorder 2023 & 2031
  155. Figure 155: Asia Pacific Antidepressants Market Revenue Share (%), by Disorder 2023 & 2031
  156. Figure 156: Asia Pacific Antidepressants Market Volume Share (%), by Disorder 2023 & 2031
  157. Figure 157: Asia Pacific Antidepressants Market Revenue (USD Billion), by Distribution Channel 2023 & 2031
  158. Figure 158: Asia Pacific Antidepressants Market Volume (million units), by Distribution Channel 2023 & 2031
  159. Figure 159: Asia Pacific Antidepressants Market Revenue Share (%), by Distribution Channel 2023 & 2031
  160. Figure 160: Asia Pacific Antidepressants Market Volume Share (%), by Distribution Channel 2023 & 2031
  161. Figure 161: Asia Pacific Antidepressants Market Revenue (USD Billion), by Country 2023 & 2031
  162. Figure 162: Asia Pacific Antidepressants Market Volume (million units), by Country 2023 & 2031
  163. Figure 163: Asia Pacific Antidepressants Market Revenue Share (%), by Country 2023 & 2031
  164. Figure 164: Asia Pacific Antidepressants Market Volume Share (%), by Country 2023 & 2031
  165. Figure 165: Latin America Antidepressants Market Revenue (USD Billion), by Drug Class 2023 & 2031
  166. Figure 166: Latin America Antidepressants Market Volume (million units), by Drug Class 2023 & 2031
  167. Figure 167: Latin America Antidepressants Market Revenue Share (%), by Drug Class 2023 & 2031
  168. Figure 168: Latin America Antidepressants Market Volume Share (%), by Drug Class 2023 & 2031
  169. Figure 169: Latin America Antidepressants Market Revenue (USD Billion), by Disorder 2023 & 2031
  170. Figure 170: Latin America Antidepressants Market Volume (million units), by Disorder 2023 & 2031
  171. Figure 171: Latin America Antidepressants Market Revenue Share (%), by Disorder 2023 & 2031
  172. Figure 172: Latin America Antidepressants Market Volume Share (%), by Disorder 2023 & 2031
  173. Figure 173: Latin America Antidepressants Market Revenue (USD Billion), by Distribution Channel 2023 & 2031
  174. Figure 174: Latin America Antidepressants Market Volume (million units), by Distribution Channel 2023 & 2031
  175. Figure 175: Latin America Antidepressants Market Revenue Share (%), by Distribution Channel 2023 & 2031
  176. Figure 176: Latin America Antidepressants Market Volume Share (%), by Distribution Channel 2023 & 2031
  177. Figure 177: Latin America Antidepressants Market Revenue (USD Billion), by Country 2023 & 2031
  178. Figure 178: Latin America Antidepressants Market Volume (million units), by Country 2023 & 2031
  179. Figure 179: Latin America Antidepressants Market Revenue Share (%), by Country 2023 & 2031
  180. Figure 180: Latin America Antidepressants Market Volume Share (%), by Country 2023 & 2031
  181. Figure 181: The Middle East & Africa Antidepressants Market Revenue (USD Billion), by Drug Class 2023 & 2031
  182. Figure 182: The Middle East & Africa Antidepressants Market Volume (million units), by Drug Class 2023 & 2031
  183. Figure 183: The Middle East & Africa Antidepressants Market Revenue Share (%), by Drug Class 2023 & 2031
  184. Figure 184: The Middle East & Africa Antidepressants Market Volume Share (%), by Drug Class 2023 & 2031
  185. Figure 185: The Middle East & Africa Antidepressants Market Revenue (USD Billion), by Disorder 2023 & 2031
  186. Figure 186: The Middle East & Africa Antidepressants Market Volume (million units), by Disorder 2023 & 2031
  187. Figure 187: The Middle East & Africa Antidepressants Market Revenue Share (%), by Disorder 2023 & 2031
  188. Figure 188: The Middle East & Africa Antidepressants Market Volume Share (%), by Disorder 2023 & 2031
  189. Figure 189: The Middle East & Africa Antidepressants Market Revenue (USD Billion), by Distribution Channel 2023 & 2031
  190. Figure 190: The Middle East & Africa Antidepressants Market Volume (million units), by Distribution Channel 2023 & 2031
  191. Figure 191: The Middle East & Africa Antidepressants Market Revenue Share (%), by Distribution Channel 2023 & 2031
  192. Figure 192: The Middle East & Africa Antidepressants Market Volume Share (%), by Distribution Channel 2023 & 2031
  193. Figure 193: The Middle East & Africa Antidepressants Market Revenue (USD Billion), by Country 2023 & 2031
  194. Figure 194: The Middle East & Africa Antidepressants Market Volume (million units), by Country 2023 & 2031
  195. Figure 195: The Middle East & Africa Antidepressants Market Revenue Share (%), by Country 2023 & 2031
  196. Figure 196: The Middle East & Africa Antidepressants Market Volume Share (%), by Country 2023 & 2031
List of Tables
  1. Table 1: Global Antidepressants Market Revenue USD Billion Forecast, by Drug Class 2018 & 2031
  2. Table 2: Global Antidepressants Market Volume million units Forecast, by Drug Class 2018 & 2031
  3. Table 3: Global Antidepressants Market Revenue USD Billion Forecast, by Disorder 2018 & 2031
  4. Table 4: Global Antidepressants Market Volume million units Forecast, by Disorder 2018 & 2031
  5. Table 5: Global Antidepressants Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
  6. Table 6: Global Antidepressants Market Volume million units Forecast, by Distribution Channel 2018 & 2031
  7. Table 7: Global Antidepressants Market Revenue USD Billion Forecast, by Region 2018 & 2031
  8. Table 8: Global Antidepressants Market Volume million units Forecast, by Region 2018 & 2031
  9. Table 9: Global Antidepressants Market Revenue USD Billion Forecast, by Drug Class 2018 & 2031
  10. Table 10: Global Antidepressants Market Volume million units Forecast, by Drug Class 2018 & 2031
  11. Table 11: Global Antidepressants Market Revenue USD Billion Forecast, by Disorder 2018 & 2031
  12. Table 12: Global Antidepressants Market Volume million units Forecast, by Disorder 2018 & 2031
  13. Table 13: Global Antidepressants Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
  14. Table 14: Global Antidepressants Market Volume million units Forecast, by Distribution Channel 2018 & 2031
  15. Table 15: Global Antidepressants Market Revenue USD Billion Forecast, by Region 2018 & 2031
  16. Table 16: Global Antidepressants Market Volume million units Forecast, by Region 2018 & 2031
  17. Table 17: Global Antidepressants Market Revenue USD Billion Forecast, by Drug Class 2018 & 2031
  18. Table 18: Global Antidepressants Market Volume million units Forecast, by Drug Class 2018 & 2031
  19. Table 19: Global Antidepressants Market Revenue USD Billion Forecast, by Disorder 2018 & 2031
  20. Table 20: Global Antidepressants Market Volume million units Forecast, by Disorder 2018 & 2031
  21. Table 21: Global Antidepressants Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
  22. Table 22: Global Antidepressants Market Volume million units Forecast, by Distribution Channel 2018 & 2031
  23. Table 23: Global Antidepressants Market Revenue USD Billion Forecast, by Country 2018 & 2031
  24. Table 24: Global Antidepressants Market Volume million units Forecast, by Country 2018 & 2031
  25. Table 25: United States Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  26. Table 26: United States Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  27. Table 27: Canada Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  28. Table 28: Canada Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  29. Table 29: Mexico Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  30. Table 30: Mexico Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  31. Table 31: Global Antidepressants Market Revenue USD Billion Forecast, by Drug Class 2018 & 2031
  32. Table 32: Global Antidepressants Market Volume million units Forecast, by Drug Class 2018 & 2031
  33. Table 33: Global Antidepressants Market Revenue USD Billion Forecast, by Disorder 2018 & 2031
  34. Table 34: Global Antidepressants Market Volume million units Forecast, by Disorder 2018 & 2031
  35. Table 35: Global Antidepressants Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
  36. Table 36: Global Antidepressants Market Volume million units Forecast, by Distribution Channel 2018 & 2031
  37. Table 37: Global Antidepressants Market Revenue USD Billion Forecast, by Country 2018 & 2031
  38. Table 38: Global Antidepressants Market Volume million units Forecast, by Country 2018 & 2031
  39. Table 39: Brazil Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  40. Table 40: Brazil Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  41. Table 41: Argentina Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  42. Table 42: Argentina Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  43. Table 43: Rest of South America Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  44. Table 44: Rest of South America Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  45. Table 45: Global Antidepressants Market Revenue USD Billion Forecast, by Drug Class 2018 & 2031
  46. Table 46: Global Antidepressants Market Volume million units Forecast, by Drug Class 2018 & 2031
  47. Table 47: Global Antidepressants Market Revenue USD Billion Forecast, by Disorder 2018 & 2031
  48. Table 48: Global Antidepressants Market Volume million units Forecast, by Disorder 2018 & 2031
  49. Table 49: Global Antidepressants Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
  50. Table 50: Global Antidepressants Market Volume million units Forecast, by Distribution Channel 2018 & 2031
  51. Table 51: Global Antidepressants Market Revenue USD Billion Forecast, by Country 2018 & 2031
  52. Table 52: Global Antidepressants Market Volume million units Forecast, by Country 2018 & 2031
  53. Table 53: Germany Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  54. Table 54: Germany Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  55. Table 55: France Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  56. Table 56: France Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  57. Table 57: Italy Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  58. Table 58: Italy Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  59. Table 59: United Kingdom Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  60. Table 60: United Kingdom Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  61. Table 61: Netherlands Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  62. Table 62: Netherlands Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  63. Table 63: Rest of Europe Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  64. Table 64: Rest of Europe Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  65. Table 65: Global Antidepressants Market Revenue USD Billion Forecast, by Drug Class 2018 & 2031
  66. Table 66: Global Antidepressants Market Volume million units Forecast, by Drug Class 2018 & 2031
  67. Table 67: Global Antidepressants Market Revenue USD Billion Forecast, by Disorder 2018 & 2031
  68. Table 68: Global Antidepressants Market Volume million units Forecast, by Disorder 2018 & 2031
  69. Table 69: Global Antidepressants Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
  70. Table 70: Global Antidepressants Market Volume million units Forecast, by Distribution Channel 2018 & 2031
  71. Table 71: Global Antidepressants Market Revenue USD Billion Forecast, by Country 2018 & 2031
  72. Table 72: Global Antidepressants Market Volume million units Forecast, by Country 2018 & 2031
  73. Table 73: China Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  74. Table 74: China Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  75. Table 75: Japan Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  76. Table 76: Japan Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  77. Table 77: India Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  78. Table 78: India Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  79. Table 79: South Korea Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  80. Table 80: South Korea Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  81. Table 81: Taiwan Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  82. Table 82: Taiwan Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  83. Table 83: Australia Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  84. Table 84: Australia Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  85. Table 85: Rest of Asia-Pacific Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  86. Table 86: Rest of Asia-Pacific Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  87. Table 87: Global Antidepressants Market Revenue USD Billion Forecast, by Drug Class 2018 & 2031
  88. Table 88: Global Antidepressants Market Volume million units Forecast, by Drug Class 2018 & 2031
  89. Table 89: Global Antidepressants Market Revenue USD Billion Forecast, by Disorder 2018 & 2031
  90. Table 90: Global Antidepressants Market Volume million units Forecast, by Disorder 2018 & 2031
  91. Table 91: Global Antidepressants Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
  92. Table 92: Global Antidepressants Market Volume million units Forecast, by Distribution Channel 2018 & 2031
  93. Table 93: Global Antidepressants Market Revenue USD Billion Forecast, by Country 2018 & 2031
  94. Table 94: Global Antidepressants Market Volume million units Forecast, by Country 2018 & 2031
  95. Table 95: Middle East Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  96. Table 96: Middle East Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  97. Table 97: Africa Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  98. Table 98: Africa Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  99. Table 99: Global Antidepressants Market Revenue USD Billion Forecast, by Drug Class 2018 & 2031
  100. Table 100: Global Antidepressants Market Volume million units Forecast, by Drug Class 2018 & 2031
  101. Table 101: Global Antidepressants Market Revenue USD Billion Forecast, by Disorder 2018 & 2031
  102. Table 102: Global Antidepressants Market Volume million units Forecast, by Disorder 2018 & 2031
  103. Table 103: Global Antidepressants Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
  104. Table 104: Global Antidepressants Market Volume million units Forecast, by Distribution Channel 2018 & 2031
  105. Table 105: Global Antidepressants Market Revenue USD Billion Forecast, by Country 2018 & 2031
  106. Table 106: Global Antidepressants Market Volume million units Forecast, by Country 2018 & 2031
  107. Table 107: By Drug Class Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  108. Table 108: By Drug Class Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  109. Table 109: By Disorder Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  110. Table 110: By Disorder Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  111. Table 111: By Distribution Channel Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  112. Table 112: By Distribution Channel Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  113. Table 113: By Country Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  114. Table 114: By Country Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  115. Table 115: Global Antidepressants Market Revenue USD Billion Forecast, by Drug Class 2018 & 2031
  116. Table 116: Global Antidepressants Market Volume million units Forecast, by Drug Class 2018 & 2031
  117. Table 117: Global Antidepressants Market Revenue USD Billion Forecast, by Disorder 2018 & 2031
  118. Table 118: Global Antidepressants Market Volume million units Forecast, by Disorder 2018 & 2031
  119. Table 119: Global Antidepressants Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
  120. Table 120: Global Antidepressants Market Volume million units Forecast, by Distribution Channel 2018 & 2031
  121. Table 121: Global Antidepressants Market Revenue USD Billion Forecast, by Country 2018 & 2031
  122. Table 122: Global Antidepressants Market Volume million units Forecast, by Country 2018 & 2031
  123. Table 123: By Drug Class Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  124. Table 124: By Drug Class Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  125. Table 125: By Disorder Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  126. Table 126: By Disorder Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  127. Table 127: By Distribution Channel Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  128. Table 128: By Distribution Channel Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  129. Table 129: By Country Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  130. Table 130: By Country Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  131. Table 131: Global Antidepressants Market Revenue USD Billion Forecast, by Drug Class 2018 & 2031
  132. Table 132: Global Antidepressants Market Volume million units Forecast, by Drug Class 2018 & 2031
  133. Table 133: Global Antidepressants Market Revenue USD Billion Forecast, by Disorder 2018 & 2031
  134. Table 134: Global Antidepressants Market Volume million units Forecast, by Disorder 2018 & 2031
  135. Table 135: Global Antidepressants Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
  136. Table 136: Global Antidepressants Market Volume million units Forecast, by Distribution Channel 2018 & 2031
  137. Table 137: Global Antidepressants Market Revenue USD Billion Forecast, by Country 2018 & 2031
  138. Table 138: Global Antidepressants Market Volume million units Forecast, by Country 2018 & 2031
  139. Table 139: By Drug Class Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  140. Table 140: By Drug Class Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  141. Table 141: By Disorder Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  142. Table 142: By Disorder Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  143. Table 143: By Distribution Channel Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  144. Table 144: By Distribution Channel Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  145. Table 145: By Country Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  146. Table 146: By Country Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  147. Table 147: Global Antidepressants Market Revenue USD Billion Forecast, by Drug Class 2018 & 2031
  148. Table 148: Global Antidepressants Market Volume million units Forecast, by Drug Class 2018 & 2031
  149. Table 149: Global Antidepressants Market Revenue USD Billion Forecast, by Disorder 2018 & 2031
  150. Table 150: Global Antidepressants Market Volume million units Forecast, by Disorder 2018 & 2031
  151. Table 151: Global Antidepressants Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
  152. Table 152: Global Antidepressants Market Volume million units Forecast, by Distribution Channel 2018 & 2031
  153. Table 153: Global Antidepressants Market Revenue USD Billion Forecast, by Country 2018 & 2031
  154. Table 154: Global Antidepressants Market Volume million units Forecast, by Country 2018 & 2031
  155. Table 155: By Drug Class Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  156. Table 156: By Drug Class Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  157. Table 157: By Disorder Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  158. Table 158: By Disorder Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  159. Table 159: By Distribution Channel Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  160. Table 160: By Distribution Channel Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  161. Table 161: By Country Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  162. Table 162: By Country Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  163. Table 163: Global Antidepressants Market Revenue USD Billion Forecast, by Drug Class 2018 & 2031
  164. Table 164: Global Antidepressants Market Volume million units Forecast, by Drug Class 2018 & 2031
  165. Table 165: Global Antidepressants Market Revenue USD Billion Forecast, by Disorder 2018 & 2031
  166. Table 166: Global Antidepressants Market Volume million units Forecast, by Disorder 2018 & 2031
  167. Table 167: Global Antidepressants Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
  168. Table 168: Global Antidepressants Market Volume million units Forecast, by Distribution Channel 2018 & 2031
  169. Table 169: Global Antidepressants Market Revenue USD Billion Forecast, by Country 2018 & 2031
  170. Table 170: Global Antidepressants Market Volume million units Forecast, by Country 2018 & 2031
  171. Table 171: By Drug Class Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  172. Table 172: By Drug Class Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  173. Table 173: By Disorder Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  174. Table 174: By Disorder Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  175. Table 175: By Distribution Channel Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  176. Table 176: By Distribution Channel Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
  177. Table 177: By Country Antidepressants Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  178. Table 178: By Country Antidepressants Market Volume (million units) Forecast, by Application 2018 & 2031
AspectsDetails
Study Period 2018-2032
Base Year 2023
Estimated Year 2024
Forecast Period2024-2032
Historical Period2018-2023
Growth RateCAGR of 21.2% from 2018-2032
Segmentation
    • By Drug Class
      • Selective Serotonin Reuptake Inhibitors
      • Serotonin & Norepinephrine Reuptake Inhibitors
      • Atypical Antidepressants
      • Tricyclic Antidepressants
    • By Disorder
      • Major Depressive Disorder
      • Obsessive-Compulsive Disorder
      • Generalized Anxiety Disorder
    • By Distribution Channel
      • Hospital Pharmacy
      • Retail Pharmacy
  • By Geography
    • North America
      • By Drug Class
      • By Disorder
      • By Distribution Channel
      • By Country
    • Europe
      • By Drug Class
      • By Disorder
      • By Distribution Channel
      • By Country
    • Asia Pacific
      • By Drug Class
      • By Disorder
      • By Distribution Channel
      • By Country
    • Latin America
      • By Drug Class
      • By Disorder
      • By Distribution Channel
      • By Country
    • The Middle East & Africa
      • By Drug Class
      • By Disorder
      • By Distribution Channel
      • By Country

STEP 1 - Identification of Relevant Samples Size from Population Database

Step Chart
bar chart
method chart

STEP 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

approach chart
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segemnts, product and application.

Note* : In applicable scenarios

STEP 3 - Data Sources

Primary Research

  • Web Analytics
  • Survey Reports
  • Research Institute
  • Latest Research Reports
  • Opinion Leaders

Secondary Research

  • Annual Reports
  • White Paper
  • Latest Press Release
  • Industry Association
  • Paid Database
  • Investor Presentations
approach chart

STEP 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally after gathering mix and scattered data from wide range of sources, data is triangull- ated and correlated to come up with estimated figures which are further validated through primary mediums, or industry experts, opinion leader.
Get Free Sample
Hover animation image
 Pre Order Enquiry Request discount

Pricing

$4850
Single User License:
  • Only one user can access this report at time
  • users are not allowed to take a print out of the report PDF
$5850
Multi User License:
  • The report will be emailed to you in PDF format.
  • This is a multi-user license, allowing 1-10 employees within your organisation to access the report.
$6850
Corporate User License:
  • Sharable and Printable among all employees of your organization
  • Excel Raw data with access to full quantitative & financial market insights
  • Customization at no additional cost within the scope of the report
  • Graphs and Charts can be used during presentation
BUY NOW
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo

Tailored for you

  • In-depth Analysis Tailored to Specified Regions or Segments
  • Company Profiles Customized to User Preferences
  • Comprehensive Insights Focused on Specific Segments or Regions
  • Customized Evaluation of Competitive Landscape to Meet Your Needs
  • Tailored Customization to Address Other Specific Requirements
Ask for customization

I have received the report already. Thanks you for your help.it has been a pleasure working with you. Thank you againg for a good quality report

quotation
avatar

Jared Wan

Analyst at Providence Strategic Partners at Petaling Jaya

As requested- presale engagement was good, your perseverance, support and prompt responses were noted. Your follow up with vm’s were much appreciated. Happy with the final report and post sales by your team.

quotation
avatar

Shankar Godavarti

Global Product, Quality & Strategy Executive- Principal Innovator at Donaldson

The response was good, and I got what I was looking for as far as the report. Thank you for that.

quotation
avatar

Erik Perison

US TPS Business Development Manager at Thermon

About Market Research Forecast

MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.

Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.

+1 2017933837

+44 20 7097 9277

sales@marketresearchforecast.com

  • Home
  • About Us
  • Industries
    • Healthcare
    • Chemicals & Materials
    • Information & Technology
    • Machinery & Equipment
    • Energy & Power
    • Aerospace & Defense
    • Automotive & Transportation
    • Food & Beverages
    • Agriculture
    • Consumer Goods
    • Semiconductor & Electronics
    • Packaging
    • COVID-19 Analysis
  • Services
  • Contact
MRF logo
  • Home
  • About Us
  • Industries
    • Healthcare
    • Chemicals & Materials
    • Information & Technology
    • Machinery & Equipment
    • Energy & Power
    • Aerospace & Defense
    • Automotive & Transportation
    • Food & Beverages
    • Agriculture
    • Consumer Goods
    • Semiconductor & Electronics
    • Packaging
    • COVID-19 Analysis
  • Services
  • Contact
sales@marketresearchforecast.com

Business Address

Head Office

Office no. A 5010, fifth floor, Solitaire Business Hub, Near Phoenix mall, Pune, Maharashtra 411014

Contact Information

Craig Francis

Business Development Head

+1 940 441 3937

sales@marketresearchforecast.com

Extra Links

AboutContactsTestimonials
ServicesCareer

Subscribe

Get the latest updates and offers.

PackagingHealthcareAgricultureEnergy & PowerConsumer GoodsFood & BeveragesCOVID-19 AnalysisAerospace & DefenseChemicals & MaterialsMachinery & EquipmentInformation & TechnologyAutomotive & TransportationSemiconductor & Electronics

© 2024 AMA Research. All rights reserved

Privacy Policy
Terms and Conditions
FAQ

Related Reports

report thumbnailFemale Sexual Dysfunction Treatment Market

Female Sexual Dysfunction Treatment Market 2024 to Grow at 1...

report thumbnailUrinary Drainage Bags Market

Urinary Drainage Bags Market Analysis Report 2024: Market to...

report thumbnailGuidewires Market

Guidewires Market 2024 to Grow at 21.2 CAGR with XX USD mill...

report thumbnailAsia Pacific In-vitro Diagnostics Market

Asia Pacific In-vitro Diagnostics Market Analysis 2024 and F...

report thumbnailBrain Implants Market

Brain Implants Market Charting Growth Trajectories: Analysis...

report thumbnailContinuous Renal Replacement Therapy (CRRT) Market

Continuous Renal Replacement Therapy (CRRT) Market Future-pr...

report thumbnailFoot Prosthetics Market

Foot Prosthetics Market 2024 to Grow at 6.6 CAGR with 588.1 ...

report thumbnailImmunoglobulins Market

Immunoglobulins Market Decade Long Trends, Analysis and Fore...

report thumbnailNegative Pressure Wound Therapy (NPWT) Market

Negative Pressure Wound Therapy (NPWT) Market Is Set To Reac...

report thumbnailViral Vaccines Market

Viral Vaccines Market Unlocking Growth Opportunities: Analys...

report thumbnailNeurovascular Devices/Interventional Neurology Market

Neurovascular Devices/Interventional Neurology Market 2024 t...

report thumbnailU.S. Normal Saline for Parenteral Use Market

U.S. Normal Saline for Parenteral Use Market  Analysis Repor...

report thumbnailHealthcare Predictive Analytics Market

Healthcare Predictive Analytics Market Decade Long Trends, A...

report thumbnailStomach-Gastric- Cancer- Treatment Market

Stomach-Gastric- Cancer- Treatment Market Decade Long Trends...

report thumbnailBiomarkers Market

Biomarkers Market Report Probes the 38.41 USD billion Size, ...

report thumbnailAntiepileptic Drug Market

Antiepileptic Drug Market 2024-2032 Analysis: Trends, Compet...

report thumbnailSurgical Stapling Devices Market

Surgical Stapling Devices Market Insightful Analysis: Trends...

report thumbnailUrinary Catheter Market

Urinary Catheter Market Report Probes the 2.56 USD Billion S...

report thumbnailAdult Diapers Market

Adult Diapers Market Is Set To Reach 11.55 USD Billion By 20...

report thumbnailSpectacles Market

Spectacles Market 2024 to Grow at 5.7 CAGR with 91.56 USD bi...